Figure 3.

Percent of patients who identified as gender-expansive (verified by chart review) and who were taking gender-affirming hormones from those who selected “Transgender Male,” “Transgender Female,” or “Nonbinary” for Gender Identity in the electronic health record SOGI fields (1431 unique patients). (A) Percentage of patients in each category that were determined to be gender-expansive by chart review (average of 99.5%). (B) Percentage of patients in each category that were determined to be actively using gender-affirming hormones (average of 63.9%). The color coding indicates frequency of gender-expansive identity or use of gender-affirming hormones (see index on right side of figure). Not disclosed: “Choose not to disclose”; Other responses: includes “Not recorded on birth certificate,” “Uncertain”: or “Unknown for Sex Assigned at Birth”; M: “Male”; F: “Female”; TM: “Transgender male”; TF: “Transgender female”; NB: “Nonbinary.”